Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for Tenax Therapeutics, Inc Common Stock (TENX).
- Disclosed ownership: 5.4%.
- Date of event: 31 Dec 2024.
JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G/A Report for Tenax Therapeutics, Inc Common Stock (TENX)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Security
- Tenax Therapeutics, Inc Common Stock
- Symbol
- TENX
- Shares outstanding
- 3,577,444 shares
- Disclosed Ownership
- 193,182 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 12:37:36 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 5.4% ownership in Tenax Therapeutics, Inc Common Stock (TENX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 12:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.4% | 193,182 | 0 | 193,182 | Kristin Mariani | Head of North America Compliance, CCO |